From product contamination to a DUI, product liability is one of the largest exposures facing the cannabis industry. Reducing the exposure calls for continued monitoring of business exposures related to cultivation, production and distribution practices.
The German consumer affairs agency has decided there is no use for cannabinoids and European Industrial Hemp Association is taking action.
In this three-part series, Jennifer Whetzel shares how cannabis companies can make their branding shine.
Advocates clamored for the FDA to act quickly, some asked for food safety regulations and others spoke of reefer madness: Check out the highlights from the FDA public hearing on CBD here.
The University of Pennsylvania’s School of Veterinary Medicine is beginning a clinical trial to gauge the effectiveness of CBD products for joint immobility in dogs.
Manufacturers of CBD products should heed Sandler’s advice when marketing their product and engaging in interstate commerce.
Chris Dacus takes a closer look at new rules in the EU regarding vaporizing products.
With growing season coming soon, hundreds of applications have flooded the Department of Agriculture and they’ve already approved many of them.
Insights from marketing expert Caitlin Sherwood about marketing CBD products in this time of constant change.
The USPTO published a guide addressing trademarks for CBD products following the 2018 Farm Bill.
